Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline.

Authors

Gillian A. Beauchamp MD, Lehigh Valley Health NetworkFollow
Jill Hanisak CRNA, Lehigh Valley Health NetworkFollow
Alexandra Amaducci, Lehigh Valley Health NetworkFollow
Andrew L. Koons, Lehigh Valley Health NetworkFollow
Jason Laskosky PharmD, BCPS, Lehigh Valley Health NetworkFollow
Bernadette M MaronFollow
Thomas A. McLoughlin, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-1-2022

Abstract

With a brief summary of selected literature identified by a multidisciplinary panel of subject matter experts, the authors share their experience with the development of an institutional perioperative pain management guideline for patients on maintenance medication for addiction treatment (MAT), stressing the importance of perioperative continuation of opioid agonists such as methadone and partial agonists such as buprenorphine; and the discontinuation of opioid antagonists, such as naltrexone. The authors' protocol is appended as an example of a standardized approach to perioperative management of patients on MAT.

Volume

91

Issue

1

First Page

50

Last Page

57

ISSN

2162-5239

Published In/Presented At

Beauchamp, G. A., Hanisak, J. L., Amaducci, A. M., Koons, A. L., Laskosky, J., Maron, B. M., & McLoughlin, T. M. (2022). Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline. AANA journal, 91(1), 50–57.

Disciplines

Anesthesiology | Emergency Medicine | Health and Medical Administration | Substance Abuse and Addiction

PubMedID

35076384

Department(s)

Department of Anesthesiology, Department of Emergency Medicine, Department of Pharmacy

Document Type

Article